NCT06752031 Optimizing Care Transition Process for Older Colorectal Surgery Patients
| NCT ID | NCT06752031 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Colorectal Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-10-30 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-10-30 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study to test if a care transition intervention designed for older colorectal surgery patients would improve outcomes after discharge. It will assess the feasibility of the intervention.
Eligibility Criteria
Inclusion Criteria: * Adult patients (\>65 years old) * Scheduled to undergo an elective colorectal surgery procedure * Ability to provide informed consent Exclusion Criteria: * Emergent, non-elective colorectal procedures * Non-English Speaking
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06752031 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Colorectal Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06752031 currently recruiting?
Yes, NCT06752031 is actively recruiting participants. Contact the research team at scizginer1@mgh.harvard.edu for enrollment information.
Where is the NCT06752031 trial being conducted?
This trial is being conducted at Salem, United States.
Who is sponsoring the NCT06752031 clinical trial?
NCT06752031 is sponsored by Massachusetts General Hospital. The trial plans to enroll 30 participants.